sb.scorecardresearch
Advertisement

Published 19:35 IST, January 7th 2021

COVID-19: CureVac, Bayer ink agreement to produce 'hundreds of doses' of vaccine

German pharmaceutical firms Bayer and CureVac on January 6 said that they have joined forces in the development of CureVac's Covid-19 vaccine candidate. 

Reported by: Riya Baibhawi
Follow: Google News Icon
  • share
Covid-19: CureVac, Bayer ink agreement to produce 'hundreds of doses' of vaccine
null | Image: self
Advertisement

19:35 IST, January 7th 2021